Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Withdrawn 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Head & Neck 2Breast 2Gastrointestinal 1

Conditions

Neuroma, Acoustic 3

Interventions

Temozolomide 623Radiotherapy 411Bevacizumab 257Magnetic Resonance Spectroscopy 227Cyclophosphamide 179Radiosurgery 163Carboplatin 160Etoposide 132Radiation 129Vincristine 115Irinotecan 115Cisplatin 103Filgrastim 100Specimen Handling 90Nivolumab 88pembrolizumab 84Surgical Procedures, Operative 83Lomustine 83Topotecan 73Doxorubicin 61Melphalan 59Carmustine 57Radiotherapy, Intensity-Modulated 56sargramostim 53Isotretinoin 53Peripheral Blood Stem Cell Transplantation 52Granulocyte Colony-Stimulating Factor 51Chemotherapy, Adjuvant 51Blood Specimen Collection 51Erlotinib Hydrochloride 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Gentamicins × CNS × Clear all
NCT02379754 2020-09-11

Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function

Lund University

Phase 4 Withdrawn
CNS

Neuroma, Acoustic

NCT02415257 2020-09-11

Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function

Lund University

Phase 4 Withdrawn
CNS

Neuroma, Acoustic

NCT02963896 2016-11-15

ITG

University Hospital, Motol

Phase NA Completed
20 enrolled
CNS

Neuroma, Acoustic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡